Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Making meaningful progress on improving cancer outcomes will require screening to identify more cancers, and at earlier stages, when they may be more treatable. 4,5 Accomplishing this requires a ...
A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...
A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...
MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with ...
SEOUL, Korea and MENLO PARK, Calif., Oct. 16, 2025 /PRNewswire/ -- Samsung C&T (SCT), Samsung Electronics (SEC), and GRAIL, Inc. (Nasdaq: GRAL), today announced they have signed a binding Letter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback